Varied immuno-related adverse events induced by immune-check point inhibitors — Nivolumab-associated psoriasiform dermatitis related with increased serum level of interleukin-6

Varied immuno-related adverse events induced by immune-check point inhibitors — Nivolumab-associated psoriasiform dermatitis related with increased serum level of interleukin-6 —

Published:2017 Issue:2 Volume:40 Page:95-101
ISSN:0911-4300
Container-title:Japanese Journal of Clinical Immunology
language:en
Short-container-title:Jpn. J. Clin. Immunol.

Author:

OKIYAMA Naoko¹,TANAKA Ryota¹

Affiliation:

1. Department of Dermatology, Faculty of Medicine, University of Tsukuba

Publisher

Japan Society for Clinical Immunology

Subject

General Medicine,Immunology,Immunology and Allergy

Link

https://www.jstage.jst.go.jp/article/jsci/40/2/40_95/_pdf

Reference14 articles.

1. 1) Ryder, M., et al.: Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution. Endocr Relat Cancer. 21: 371-381, 2014.

2. 2) Tanaka, R., et al.: Nivolumab-induced thyroid dysfunction. Jpn J Clin Oncol. 46: 575-579, 2016.

3. 3) Tanaka, R., et al.: Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barre syndrome: a case report. Jpn J Clin Oncol. 46: 875-878, 2016.

4. 4) Liao, B., et al.: Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma. Neuro Oncol. 16: 589-593, 2014.

5. 5) Conry, R.M., et al.: Ipilimumab-induced encephalopathy with a reversible splenial lesion. Cancer Immunol Res. 3: 598-601, 2015.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitor-Induced Psoriasis;Dermatologic Clinics;2024-07

2. Perspectives on Psoriasiform Adverse Events from Immune Checkpoint Inhibitors: Lessons Learned from Our Practice;Medicina;2024-02-22

3. Strengthening the Combinational Immunotherapy from Modulating the Tumor Inflammatory Environment via Hypoxia‐Responsive Nanogels;Advanced Healthcare Materials;2023-12-17

4. Construction and Evaluation of Clinical Prediction Model for Immunotherapy-related Adverse Events and Clinical Benefit in Cancer Patients Receiving Immune Checkpoint Inhibitors Based on Serum Cytokine Levels;Journal of Immunotherapy;2023-06-19

5. Psoriasis induced by first‑line pembrolizumab in metastatic non‑small cell lung cancer: A case report;Oncology Letters;2023-06-02